Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

130 participants · First posted Jul 2, 2017

Trial of Lu-177 DOTATATE (Lutathera®) in Unlicensed Indications

110 participants · First posted Nov 7, 2023

Retrospective Analysis of Patients Re-treated With Lutetium-177 DOTATATE (Lutathera®)

31 participants · First posted Apr 18, 2023

Lutetium Lu 177 dotatate(Lutathera)

C₆₅H₈₇LuN₁₄O₁₉S₂

Lutetium-177 oxodotreotide (Curium Pharma)

Lutetium Lu-177(Lutathera, Lumark, EndolucinBeta, Lutetium (177Lu) chloride Billev (previously Illuzyce))

Lu

Laureate Institute for Brain Research

United States

Aveta Biomics, Inc.

United States

Selcuk University

Turkey

Lutetium-177 Dotatate Shows Promise in Neuroendocrine Tumors, Combination Strategies Explored

Lutetium Lu 177 Dotatate Shows Promise in Metastatic Bronchopulmonary Neuroendocrine Tumors

Lutetium Lu 177 Dotatate Demonstrates Significant Efficacy in Advanced Intracranial Meningioma Phase 2 Trial